Joseph Catanzaro, PhD

Sr. Research Analyst
Research
Sector Expertise
Additional Expertise
Biotechnology
Joe Catanzaro is a director and senior research analyst at Piper Sandler covering biotechnology. Prior to joining Piper Sandler in 2018, Catanzaro spent four years at Cowen, where he also covered biotechnology. Before making the move to Wall Street, Catanzaro worked as a research scientist at Stony Brook University in New York. His work there focused on oncogene-mediated inflammatory signaling and resulted in multiple peer-reviewed publications. Catanzaro received his bachelor’s degree from Binghamton University in biological sciences and earned his Ph.D. in genetics from Stony Brook University.

Universe Coverage

Biotechnology
AADIAadi Bioscience, Inc.
ACHLAchilles Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc.
BMEABiomea Fusion, Inc.
BDTXBlack Diamond Therapeutics, Inc.
BOLDBoundless Bio Inc.
CRDFCardiff Oncology, Inc.
CPRXCatalyst Pharmaceuticals, Inc.
CNTXContext Therapeutics, Inc.
CTMXCytomX Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
EPIXESSA Pharma, Inc.
EXELExelixis, Inc.
GILDGilead Sciences, Inc.
HALOHalozyme Therapeutics, Inc.
IMABI-Mab
IBRXImmunityBio, Inc.
IOVAIovance Biotherapeutics, Inc.
KROSKeros Therapeutics, Inc.
LPTXLeap Therapeutics, Inc.
LENZLENZ Therapeutics, Inc.
NRIXNurix Therapeutics, Inc.
RPTXRepare Therapeutics Inc.
RVMDRevolution Medicines, Inc.
SDGRSchrodinger, Inc.
TNGXTango Therapeutics, Inc.
TSBXTurnstone Biologics Corp.